GGrantIndex
Sort

130,381 grants matching hiv

Center for AIDS Prevention Studies

$1,928,195
Marguerita A Lightfoot · University Of California, San Francisco · P30 · FY2017 · MH

Central Africa International Epidemiologic Database to Evaluate AIDS

$1,927,944
Kathryn M Anastos · Albert Einstein College Of Medicine, Inc · U01 · FY2016 · AI

Modulating Stochastic Gene Expression for Cell-fate Control and Therapeutics

$1,927,847
Leor S Weinberger · Autonomous Therapeutics, Inc. · R37 · FY2025 · AI

Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-1

$1,927,304
Katharine June Bar · University Of Pennsylvania · U01 · FY2024 · AI

GH11-1152, COMMUNITY HIV PREVENTION CENTRES

$1,926,776
Sue-Ann Meehan · University Of Stellenbosch · U2G · FY2013 · GH

Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations

$1,926,146
Sandra Ann Springer · Yale University · U01 · FY2024 · DA

Evaluation of the Immunogenicity and Efficacy of HIV-1 SOSIP Envelope Protein Vaccine Delivered with or without Recombinant Viral Vector Vaccines

$1,925,712
Ronald S. Veazey · Tulane University Of Louisiana · N01 · FY2020 · AI

Community-Based VCT Tanzania

$1,925,570
Michael D Sweat · Medical University Of South Carolina · U01 · FY2009 · MH

Innate Immunity: Elucidation/Modulation - Cancer Therapy

$1,925,557
Ohio State University · P01 · FY2005 · CA

DCTD Animal Support

$1,925,432
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA

PATHOGENESIS AND TREATMENT OF ACUTE HIV INFECTION

$1,925,423
Bruce D Walker · Massachusetts General Hospital · U01 · FY2006 · AI

UNIVERSITY OF SOUTHERN CALIFORNIA CLINICAL TRIALS UNIT

$1,924,673
Fred R Sattler · University Of Southern California · U01 · FY2009 · AI

Programming HIV Immunity for Broadly Neutralizing Antibodies by Vaccination

$1,924,641
Nancy Logan Haigwood · Oregon Health & Science University · P01 · FY2011 · AI

Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine

$1,924,538
Mary E. Klotman · Duke University · P01 · FY2017 · AI

Center for Experimental Infectious Disease Research

$1,924,234
Konstantin G Kousoulas · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2007 · RR

TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells

$1,923,939
Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2017 · HG

Macrophage Targeted Therapy for HAD and HIV Disease

$1,923,686
Michael Shannon McGrath · University Of California, San Francisco · U19 · FY2009 · MH

HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA

$1,923,636
Johns Hopkins University · U01 · FY2002 · AI

Sample Collection and General Screening Protocols

$1,923,376
Lesia Dropulic · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Protein Structure

$1,923,299
Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

ADULT AIDS CLINICAL TRIALS UNIT

$1,922,822
Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2000 · AI

Addressing Louisiana's Inequities of HIV and AIDS (ALIHA)

$1,922,670
Deann Marie Gruber · Louisiana State Office Of Public Health · U62 · FY2013 · PS

Philadelphia IMPAACT Clinical Trials Unit

$1,922,500
Steven Daniel Douglas · Children'S Hosp Of Philadelphia · UM1 · FY2012 · AI

Prevention of AIDS

$1,921,959
Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

AIDS CLINICAL TRIALS UNIT

$1,921,768
Stanford University · U01 · FY2001 · AI